Telomir Pharmaceuticals, Common Stock Buy Hold or Sell Recommendation
| TELO Stock | 4.91 0.03 0.61% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Telomir Pharmaceuticals, Common is 'Cautious Hold'. The recommendation algorithm takes into account all of Telomir Pharmaceuticals,'s available fundamental, technical, and predictive indicators you will find on this site.
Check out Telomir Pharmaceuticals, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Telomir and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Telomir |
Execute Telomir Pharmaceuticals, Buy or Sell Advice
The Telomir recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telomir Pharmaceuticals, Common. Macroaxis does not own or have any residual interests in Telomir Pharmaceuticals, Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telomir Pharmaceuticals,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Telomir Pharmaceuticals, Trading Alerts and Improvement Suggestions
| Telomir Pharmaceuticals, generated a negative expected return over the last 90 days | |
| Telomir Pharmaceuticals, has high historical volatility and very poor performance | |
| Telomir Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (13.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telomir Pharmaceuticals, generates negative cash flow from operations | |
| Telomir Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 43.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from benzinga.com: Telomir Pharmaceuticals Secures 1 Million At 7 Per Share In No-Warrant, Restricted Stock Deal, Underscoring Investor Confidence With A 20 percent Premium Valuation |
Telomir Pharmaceuticals, Returns Distribution Density
The distribution of Telomir Pharmaceuticals,'s historical returns is an attempt to chart the uncertainty of Telomir Pharmaceuticals,'s future price movements. The chart of the probability distribution of Telomir Pharmaceuticals, daily returns describes the distribution of returns around its average expected value. We use Telomir Pharmaceuticals, Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telomir Pharmaceuticals, returns is essential to provide solid investment advice for Telomir Pharmaceuticals,.
| Mean Return | -0.0092 | Value At Risk | -9.07 | Potential Upside | 14.82 | Standard Deviation | 7.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telomir Pharmaceuticals, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Telomir Pharmaceuticals, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Telomir Pharmaceuticals, or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Telomir Pharmaceuticals,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Telomir stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 2.08 | |
σ | Overall volatility | 7.98 | |
Ir | Information ratio | -0.0097 |
Telomir Pharmaceuticals, Volatility Alert
Telomir Pharmaceuticals, Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Telomir Pharmaceuticals,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Telomir Pharmaceuticals,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Telomir Pharmaceuticals, Fundamentals Vs Peers
Comparing Telomir Pharmaceuticals,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Telomir Pharmaceuticals,'s direct or indirect competition across all of the common fundamentals between Telomir Pharmaceuticals, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Telomir Pharmaceuticals, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Telomir Pharmaceuticals,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Telomir Pharmaceuticals, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Telomir Pharmaceuticals, to competition |
| Fundamentals | Telomir Pharmaceuticals, | Peer Average |
| Return On Equity | -17.53 | -0.31 |
| Return On Asset | -2.05 | -0.14 |
| Current Valuation | 147.08 M | 16.62 B |
| Shares Outstanding | 29.75 M | 571.82 M |
| Shares Owned By Insiders | 42.66 % | 10.09 % |
| Shares Owned By Institutions | 6.90 % | 39.21 % |
| Number Of Shares Shorted | 650.6 K | 4.71 M |
| Price To Book | 332.47 X | 9.51 X |
| EBITDA | (11.43 M) | 3.9 B |
| Net Income | (13.07 M) | 570.98 M |
| Total Debt | 101 K | 5.32 B |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (3.86 M) | 971.22 M |
| Short Ratio | 5.77 X | 4.00 X |
| Earnings Per Share | (0.78) X | 3.12 X |
| Target Price | 12.15 | |
| Number Of Employees | 1 | 18.84 K |
| Market Capitalization | 146.98 M | 19.03 B |
| Total Asset | 4.77 M | 29.47 B |
| Retained Earnings | (14.06 M) | 9.33 B |
| Working Capital | (900.34 K) | 1.48 B |
| Net Asset | 4.77 M |
Note: Acquisition by Yanez Michelle of 200000 shares of Telomir Pharmaceuticals, at 5.02 subject to Rule 16b-3 [view details]
Telomir Pharmaceuticals, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telomir . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 8542.58 | |||
| Daily Balance Of Power | (0.09) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 4.97 | |||
| Day Typical Price | 4.95 | |||
| Price Action Indicator | (0.08) | |||
| Period Momentum Indicator | (0.03) |
About Telomir Pharmaceuticals, Buy or Sell Advice
When is the right time to buy or sell Telomir Pharmaceuticals, Common? Buying financial instruments such as Telomir Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Telomir Pharmaceuticals, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Measuring and Control Equipment Thematic Idea Now
Measuring and Control Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Measuring and Control Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Measuring and Control Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Telomir Pharmaceuticals, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.78) | Return On Assets (2.05) | Return On Equity (17.53) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.